Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTK 0796 vs Linezolid in cSSSI
NCT00865280Phase 3Terminated
- Sponsor
- Paratek Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Apr 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omadacycline in Complicated skin and skin structure infection (cSSSI), sponsored by Paratek Pharmaceuticals. Started Apr 2009; status: terminated.
02
Drugs
omadacycline
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on NCT00865280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00865280.